In vitro vs in vivo

These two Latin phrases mark a big divide in how strong a finding is. In vitro means “in glass” — research done in a dish, test tube, or on isolated cells, outside a living body. In vivo means “in the living” — research done in a whole organism, an animal or a person.

The difference isn’t trivia; it’s about how much a result can be trusted. A compound in a dish is meeting cells with nothing in the way. Inside a living body it has to survive digestion or the bloodstream, get past the liver, reach the right tissue at a high enough level, and not trip other systems along the way. Plenty of substances that look spectacular in vitro do little in vivo because they never make that whole journey.

Take semaglutide as a concrete example. A researcher might first apply it to receptor-bearing cells in vitro to see whether those cells respond under controlled conditions. An in-vivo study would then test it in a whole animal or person, where bioavailability, metabolism, and effects across multiple organs all enter the picture. The dish can show that a biological interaction is possible; the living-body study shows what happens when the rest of biology joins in.

An everyday parallel: a recipe that works flawlessly in a controlled test kitchen doesn’t always survive a chaotic dinner rush. Same dish, much messier conditions.

Why it matters when you’re reading about peptides: a lot of eye-catching claims trace back to in-vitro studies — “kills cancer cells in a dish,” “boosts collagen in cultured cells.” That’s a real starting signal, and worth being excited about, but it sits below in-vivo animal work, which sits below human trials. When you see a claim, it’s always worth asking: in a dish, or in a body?